Hydrocision's Patent Portfolio is Expanding: Twenty-seventh Patent is Allowed

BILLERICA, Mass.--(BUSINESS WIRE)--HydroCision Inc. (www.hydrocision.com) announced today that its patent application U.S. 2004/228736 for its fluidjet products has been allowed and will be its 27th patent to issue worldwide. Fluidjet products using HydroCision’s proprietary technology have now been successfully used in more than 15,000 spine, arthroscopic, and wound debridement procedures combined –firmly establishing HydroSurgery as a major platform in surgery. The Company’s family of fluidjet products, which is covered in its expanding worldwide intellectual property portfolio, empowers surgeons to simultaneously cut, ablate, and remove hard and soft tissue quickly, safely, and effectively without the collateral thermal or mechanical trauma of other surgical modalities.